Folgen
Jiasen He
Jiasen He
MD Anderson
Bestätigte E-Mail-Adresse bei mdanderson.org
Titel
Zitiert von
Zitiert von
Jahr
Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
F Munir, V Hardit, IN Sheikh, S AlQahtani, J He, B Cuglievan, C Hosing, ...
International journal of molecular sciences 24 (12), 10095, 2023
302023
Venetoclax for acute myeloid leukemia in pediatric patients: a Texas Medical Center experience
A Trabal, A Gibson, J He, D McCall, M Roth, C Nuñez, M Garcia, ...
Cancers 15 (7), 1983, 2023
252023
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
B Cuglievan, J Connors, J He, S Khazal, S Yedururi, J Dai, S Garces, ...
Leukemia 37 (9), 1767-1778, 2023
222023
Combining CAR T cell therapy and oncolytic Virotherapy for pediatric solid tumors: a promising option
J He, F Munir, D Ragoonanan, W Zaky, SJ Khazal, P Tewari, J Fueyo, ...
Immuno 3 (1), 37-56, 2023
132023
Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
F Munir, J He, J Connors, M Garcia, A Gibson, D McCall, C Nunez, ...
Translational Pediatrics 12 (3), 487, 2023
62023
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia
J He, F Munir, S Catueno, JS Connors, A Gibson, L Robusto, D McCall, ...
Cancers 16 (5), 858, 2024
32024
Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm
J He, MB Garcia, JS Connors, CA Nuñez, AE Quesada, A Gibson, M Roth, ...
Journal of Pediatric Hematology/Oncology 45 (8), e1001-e1004, 2023
32023
The emerging field of viroimmunotherapy for pediatric brain tumors
M Garcia-Moure, V Laspidea, S Gupta, AG Gillard, S Khatua, ...
Neuro-oncology 26 (11), 1981-1993, 2024
12024
Increased Neonatal Mortality and Increasing Rate of Cerebral Venous Sinus Thrombosis in Hospitalized Children: A Pediatric Health Information System Database Study
J He, NA Montanez, S Fraser, A Barnett, C Silos, K Smith, LV Srivaths
Blood 142, 133, 2023
12023
Adjuvant therapy with oncolytic adenovirus Delta-24-RGDOX after intratumoral adoptive T-cell therapy promotes antigen spread to sustain systemic antitumor immunity
H Jiang, DH Shin, Y Yi, X Fan, J Gumin, J He, AG Gillard, FF Lang, ...
Cancer Research Communications 3 (6), 1118-1131, 2023
12023
Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer
J He, J Connors, A Meador, S Xu, H Meador, H Jiang, J Fueyo, ...
Neuro-Oncology, noae243, 2024
2024
EXTH-21. WINNING THE TUG OF WAR BETWEEN VIRUS AND TUMOR IMMUNODOMINANCE IN GLIOMAS TREATED WITH ONCOLYTIC ADENOVIRUSES USING TOLEROGENIC STRATEGIES
D Ho Shin, B Ozpolat, A Gillard, M Garcia-Moure, H Jiang, A Lopez-Rivas, ...
Neuro-Oncology 26 (Supplement_8), viii241-viii241, 2024
2024
EXTH-34. ACETYLATION SUPPRESSION MEETS ONCOLYTIC VIRUSES FOR THE TREATMENT OF PEDIATRIC DIFFUSE MIDLINE GLIOMA
A Parthasarathy, MG Moure, J He, A Gillard, A Paparella, DH Shin, ...
Neuro-Oncology 26 (Supplement_8), viii244-viii244, 2024
2024
IMMU-48. CRACKING THE ROLE OF ONCOMETABOLITES IN VIROIMMUNOTHERAPY FOR PEDIATRIC MALIGNANT BRAIN TUMORS
MG Moure, AR Lopez-Rivas, A Parthasarathy, DH Shin, H Jiang, J He, ...
Neuro-Oncology 26 (Supplement_8), viii163-viii163, 2024
2024
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
A Gibson, S Dickson, D McCall, M Garcia, J Connors, J He, M Roth, ...
Pediatric Blood & Cancer, e31286, 2024
2024
733 Antitumor activity of CAR T cells potentiated by oncolytic adenoviruses armed with immune stimulators
H Jiang, J He, A Duran, X Fan, DH Shin, A Parthasarathy, AG Gillard, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
1001 Targeting the immunometabolic factor AhR boosts glioma viroimmunotherapy
AR Lopez-Rivas, AG Gillard, A Parthasarathy, DH Shin, MG Moure, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
774 Refocusing on tumors: overcoming antiviral immunity in oncolytic virotherapy
DH Shin, B Ozpolat, AG Gillard, MG Moure, H Jiang, A Lopez-Rivas, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
997 Unlocking the therapeutic potential of glioma virotherapy: NONO and cGAMP as key regulators of innate immune activation
AG Gillard, DH Shin, V Laspidea, SK Singh, LA Hampton, H Jiang, X Fan, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
827 Viroimmunotherapy combined with acetylation suppression: advanced therapeutics for pediatric diffuse midline gliomas
A Parthasarathy, MG Moure, J He, AG Gillard, A Paparella, DH Shin, ...
Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20